Calibrate

Calibrate Health, Inc., known as Calibrate, is a telemedicine and metabolic health company based in New York, NY.

Founded in 2020 by CEO Isabelle Kenyon, Calibrate aims to address the obesity crisis through an integrated approach that combines clinical care, behavior change, and evidence-based coaching. The company offers a subscription-based "Metabolic Reset Program," which includes FDA-approved medications, one-on-one virtual coaching, and a digital curriculum designed for chronic weight management. Calibrate serves both individual consumers and enterprise clients, including employers and health plans. The program emphasizes personalized support, with dedicated health coaches guiding members through lifestyle changes and medication management. Members have reported significant weight loss and health improvements, with many achieving an average weight loss of 15% to 19% over three years. With a focus on sustainable outcomes, Calibrate is positioned as a comprehensive solution in the weight-loss industry, integrating medication with behavioral strategies to promote long-term health.